Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Mark Nehler

Concepts (413)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peripheral Arterial Disease
34
2026
507
4.210
Why?
Ischemia
30
2024
421
3.790
Why?
Lower Extremity
23
2026
453
2.390
Why?
Internship and Residency
19
2026
1281
2.310
Why?
Rivaroxaban
21
2026
270
2.180
Why?
Vascular Surgical Procedures
26
2026
352
2.150
Why?
General Surgery
12
2026
217
2.110
Why?
Endovascular Procedures
12
2026
390
1.590
Why?
Platelet Aggregation Inhibitors
19
2026
499
1.530
Why?
Leg
14
2007
246
1.360
Why?
Aspirin
17
2026
405
1.330
Why?
Factor Xa Inhibitors
11
2026
195
1.310
Why?
Peripheral Vascular Diseases
12
2022
102
1.240
Why?
Limb Salvage
11
2026
74
0.980
Why?
Blood Vessel Prosthesis Implantation
6
2023
219
0.930
Why?
Surgeons
4
2021
351
0.790
Why?
Femoral Artery
10
2023
183
0.770
Why?
Vascular System Injuries
5
2025
79
0.760
Why?
Education, Medical, Graduate
7
2026
568
0.740
Why?
Arterial Occlusive Diseases
7
2008
88
0.740
Why?
Thrombosis
6
2025
398
0.730
Why?
Treatment Outcome
48
2026
11821
0.720
Why?
Risk Factors
37
2026
10921
0.640
Why?
Aortic Aneurysm, Abdominal
3
2017
164
0.630
Why?
Career Choice
4
2024
237
0.630
Why?
Popliteal Artery
7
2023
60
0.630
Why?
Intermittent Claudication
12
2022
121
0.620
Why?
Puerperal Disorders
1
2020
35
0.610
Why?
Pregnancy Complications, Cardiovascular
1
2020
83
0.600
Why?
Venous Thromboembolism
4
2025
332
0.570
Why?
Personnel Selection
3
2018
90
0.560
Why?
Vascular Patency
13
2023
115
0.540
Why?
Time Factors
22
2026
7109
0.540
Why?
Aged
52
2026
26432
0.530
Why?
Humans
121
2026
146342
0.530
Why?
Postoperative Complications
12
2024
3034
0.520
Why?
Male
78
2026
73396
0.510
Why?
Risk Assessment
16
2025
3712
0.500
Why?
Coronary Artery Disease
5
2024
751
0.490
Why?
Female
73
2026
79499
0.480
Why?
Quality Indicators, Health Care
3
2016
343
0.460
Why?
Elective Surgical Procedures
2
2017
216
0.450
Why?
Middle Aged
53
2026
36619
0.440
Why?
Mentors
2
2020
217
0.440
Why?
Clinical Competence
4
2022
1272
0.430
Why?
Arteriovenous Shunt, Surgical
2
2011
21
0.400
Why?
Incidence
11
2025
2936
0.390
Why?
Angioplasty, Balloon
3
2023
92
0.380
Why?
Renal Dialysis
3
2013
461
0.370
Why?
Aged, 80 and over
23
2026
8391
0.370
Why?
Upper Extremity
2
2011
114
0.370
Why?
Drug Therapy, Combination
10
2026
1036
0.360
Why?
Retrospective Studies
28
2025
17438
0.360
Why?
Paclitaxel
3
2021
260
0.360
Why?
Patient Care Management
1
2011
54
0.330
Why?
Kidney Failure, Chronic
4
2013
589
0.320
Why?
Alprostadil
2
2007
29
0.310
Why?
Medicaid
1
2014
477
0.300
Why?
Activities of Daily Living
4
2006
442
0.300
Why?
Adult
35
2026
41087
0.290
Why?
Quality of Life
6
2022
3200
0.290
Why?
Wound Healing
5
2009
354
0.280
Why?
Patient Readmission
5
2023
778
0.280
Why?
Continuity of Patient Care
1
2011
298
0.280
Why?
United States
18
2025
16136
0.270
Why?
Curriculum
6
2026
1079
0.270
Why?
Drug-Eluting Stents
2
2021
88
0.270
Why?
Brain Ischemia
2
2022
362
0.270
Why?
Medicare
1
2014
920
0.270
Why?
Double-Blind Method
10
2026
2070
0.260
Why?
Kidney Diseases
2
2011
428
0.260
Why?
Comorbidity
7
2017
1665
0.260
Why?
Ribs
2
2016
35
0.250
Why?
Students, Medical
2
2023
383
0.250
Why?
Hemorrhage
8
2026
825
0.250
Why?
Computer Simulation
1
2011
1014
0.240
Why?
Prodrugs
1
2007
54
0.240
Why?
Decision Support Techniques
2
2021
478
0.240
Why?
Stroke
3
2022
1287
0.240
Why?
Surveys and Questionnaires
10
2024
6073
0.240
Why?
Critical Illness
6
2020
908
0.230
Why?
Myocardial Infarction
3
2022
1215
0.230
Why?
Thoracic Outlet Syndrome
2
2016
14
0.230
Why?
Atherosclerosis
2
2020
410
0.230
Why?
Software
1
2011
676
0.230
Why?
Venous Thrombosis
2
2025
199
0.230
Why?
Anticoagulants
5
2025
746
0.220
Why?
Neoplasms
1
2021
2954
0.220
Why?
Catheterization, Peripheral
2
2009
116
0.220
Why?
Stress, Psychological
2
2026
1171
0.220
Why?
Graft Occlusion, Vascular
3
2011
39
0.210
Why?
Femoral Vein
3
2008
36
0.210
Why?
Cardiovascular Surgical Procedures
2
2001
31
0.210
Why?
Professional-Family Relations
1
2026
158
0.210
Why?
Iliac Aneurysm
2
2022
17
0.210
Why?
Attitude of Health Personnel
3
2024
1219
0.210
Why?
Reoperation
10
2014
645
0.210
Why?
Parental Leave
1
2024
27
0.200
Why?
Carotid Stenosis
2
1996
103
0.200
Why?
Chi-Square Distribution
3
2017
517
0.200
Why?
Urology
1
2024
63
0.200
Why?
Ultrasonography, Doppler
2
2021
122
0.200
Why?
Fibrinolytic Agents
3
2022
303
0.190
Why?
Acute Disease
4
2021
1038
0.190
Why?
Diabetes Complications
3
2015
219
0.190
Why?
Cranial Nerve Injuries
1
2023
4
0.190
Why?
Patient Care Team
2
2024
701
0.190
Why?
Carotid Body Tumor
1
2023
5
0.190
Why?
Fibrin Fibrinogen Degradation Products
1
2023
92
0.190
Why?
Diabetic Foot
2
2019
25
0.180
Why?
Academic Medical Centers
3
2017
561
0.180
Why?
Pulmonary Embolism
1
2025
246
0.180
Why?
Cholesterol, LDL
1
2024
363
0.180
Why?
Meditation
1
2022
34
0.180
Why?
Antifibrinolytic Agents
1
2023
68
0.180
Why?
Tibial Arteries
4
2008
14
0.180
Why?
Thrombolytic Therapy
1
2003
165
0.170
Why?
Smoking Cessation
2
2002
442
0.170
Why?
Aortic Aneurysm, Thoracic
1
2023
135
0.170
Why?
Blood Vessel Prosthesis
3
2022
133
0.170
Why?
Blood Coagulation Disorders
1
2023
190
0.160
Why?
Heparin
3
2023
247
0.160
Why?
Faculty, Medical
1
2024
309
0.160
Why?
Hemostatic Techniques
1
2001
50
0.160
Why?
Hospital Departments
1
2020
9
0.160
Why?
Outpatients
1
2024
440
0.160
Why?
Aortic Diseases
1
2001
125
0.160
Why?
Specialties, Surgical
2
2017
88
0.160
Why?
Suture Techniques
1
2001
138
0.150
Why?
Quality Improvement
2
2022
1354
0.150
Why?
Blood Pressure Determination
1
2021
143
0.150
Why?
Hyperlipidemias
1
2001
120
0.150
Why?
Forefoot, Human
1
1999
1
0.150
Why?
Multivariate Analysis
4
2019
1543
0.150
Why?
Toes
1
1999
16
0.150
Why?
Mentoring
1
2022
166
0.150
Why?
Communication
1
2026
980
0.150
Why?
Burnout, Professional
2
2026
493
0.150
Why?
Logistic Models
3
2017
2126
0.150
Why?
Aneurysm
2
1997
37
0.150
Why?
Canagliflozin
1
2019
11
0.150
Why?
Proportional Hazards Models
3
2021
1331
0.140
Why?
Self Concept
1
2021
257
0.140
Why?
Counseling
1
2002
406
0.140
Why?
Databases, Factual
4
2017
1493
0.140
Why?
Walking
4
2022
546
0.140
Why?
Clinical Clerkship
1
2020
111
0.140
Why?
Patient Selection
4
2014
728
0.140
Why?
Chronic Disease
6
2011
1827
0.140
Why?
Carotid Artery Diseases
1
2019
70
0.140
Why?
Drug Prescriptions
1
2020
314
0.140
Why?
Blood Vessels
2
1998
164
0.140
Why?
Iatrogenic Disease
1
1998
74
0.130
Why?
Extremities
2
2009
142
0.130
Why?
School Admission Criteria
1
2018
35
0.130
Why?
Arm
2
2004
111
0.130
Why?
Odds Ratio
3
2016
1077
0.130
Why?
Randomized Controlled Trials as Topic
5
2024
1763
0.130
Why?
Cardiovascular Diseases
5
2024
2219
0.130
Why?
Arteriosclerosis
1
1997
82
0.130
Why?
Physician Executives
1
2017
29
0.130
Why?
Ultrasonography, Doppler, Duplex
2
1996
39
0.130
Why?
Exercise Therapy
2
2001
488
0.130
Why?
Follow-Up Studies
9
2021
5439
0.130
Why?
Cost of Illness
1
2019
323
0.130
Why?
Homocysteine
1
1997
152
0.130
Why?
Subclavian Artery
1
1997
28
0.130
Why?
Vascular Diseases
2
2015
252
0.130
Why?
Diabetes Mellitus
3
2021
1101
0.120
Why?
Military Personnel
1
2025
726
0.120
Why?
Hospitalization
2
2025
2475
0.120
Why?
Tertiary Care Centers
1
2017
196
0.120
Why?
Incidental Findings
1
2016
81
0.120
Why?
Vascular Malformations
1
2016
53
0.120
Why?
Endarterectomy, Carotid
2
2013
63
0.110
Why?
Sepsis
2
2016
669
0.110
Why?
Osteotomy
1
2016
138
0.110
Why?
Survival Rate
4
2021
2092
0.110
Why?
Interprofessional Relations
1
2017
275
0.110
Why?
Popliteal Vein
1
1994
5
0.110
Why?
Kaplan-Meier Estimate
4
2021
970
0.110
Why?
Hypertension
2
2001
1272
0.110
Why?
Multidetector Computed Tomography
1
2014
40
0.100
Why?
Disease Progression
3
2014
2867
0.100
Why?
Endarterectomy
1
1993
5
0.100
Why?
Thoracotomy
1
2014
87
0.100
Why?
Premedication
1
1993
45
0.100
Why?
Bandages
1
1993
38
0.100
Why?
Registries
4
2025
2400
0.100
Why?
Multiple Trauma
1
2014
118
0.100
Why?
Surgery, Computer-Assisted
1
2014
87
0.100
Why?
Young Adult
7
2025
14330
0.100
Why?
Recurrence
4
2014
1133
0.100
Why?
Program Evaluation
1
2017
952
0.090
Why?
Ulnar Artery
1
1992
4
0.090
Why?
Recovery of Function
3
2011
725
0.090
Why?
Injury Severity Score
3
2021
572
0.090
Why?
Ischemic Attack, Transient
1
1993
71
0.090
Why?
Research Design
2
2009
1143
0.090
Why?
Life Tables
3
1998
21
0.090
Why?
Radial Artery
1
1992
74
0.090
Why?
Health Knowledge, Attitudes, Practice
1
2021
1408
0.090
Why?
Renal Insufficiency
1
2014
173
0.090
Why?
Fingers
1
1992
106
0.090
Why?
Predictive Value of Tests
4
2021
2113
0.090
Why?
Seasons
1
2014
540
0.090
Why?
Angiography
2
2024
206
0.090
Why?
Adolescent
8
2025
22557
0.090
Why?
Analgesics, Opioid
1
2020
1221
0.090
Why?
Research Personnel
1
2013
190
0.090
Why?
Oregon
1
2011
83
0.080
Why?
Thrombectomy
2
2003
79
0.080
Why?
Aorta, Thoracic
1
2014
284
0.080
Why?
Pregnancy
2
2024
7230
0.080
Why?
Prognosis
5
2021
4351
0.080
Why?
Efficiency
1
2011
102
0.080
Why?
Arteries
2
2022
261
0.080
Why?
Catheterization
2
2003
179
0.080
Why?
Controlled Clinical Trials as Topic
1
2009
26
0.080
Why?
Device Approval
1
2009
19
0.080
Why?
Reproducibility of Results
3
2021
3416
0.080
Why?
Fellowships and Scholarships
1
2013
355
0.070
Why?
Disability Evaluation
1
2011
297
0.070
Why?
Risk Management
3
2007
81
0.070
Why?
Workload
1
2011
170
0.070
Why?
Hypoglycemic Agents
1
2019
1412
0.070
Why?
Coated Materials, Biocompatible
2
2023
64
0.070
Why?
Safety
1
2011
347
0.070
Why?
Axillary Vein
1
2008
5
0.070
Why?
Skin
1
1993
701
0.070
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
449
0.070
Why?
Saphenous Vein
3
1998
36
0.070
Why?
Global Health
2
2021
403
0.070
Why?
Radiography
4
2015
861
0.070
Why?
Dose-Response Relationship, Drug
3
2021
2022
0.070
Why?
Athletic Injuries
1
2014
575
0.060
Why?
Antineoplastic Agents, Phytogenic
2
2021
178
0.060
Why?
Family Practice
2
2020
422
0.060
Why?
Colorado
3
2016
4595
0.060
Why?
Practice Guidelines as Topic
2
2011
1591
0.060
Why?
Brachial Artery
1
2008
207
0.060
Why?
Prevalence
1
2014
2861
0.060
Why?
Biomedical Research
1
2013
729
0.060
Why?
Iloprost
1
2006
45
0.060
Why?
Chemotherapy, Adjuvant
1
2007
429
0.060
Why?
Exercise Test
3
2011
637
0.050
Why?
Carotid Artery, Internal
2
1996
45
0.050
Why?
Prospective Studies
5
2021
8123
0.050
Why?
United States Department of Defense
1
2025
26
0.050
Why?
Regional Blood Flow
2
1999
507
0.050
Why?
Sulfonic Acids
1
2004
14
0.050
Why?
United States Department of Veterans Affairs
1
2009
777
0.050
Why?
Thrombophilia
1
2025
89
0.050
Why?
Acetates
1
2004
78
0.050
Why?
Diabetes Mellitus, Type 2
1
2019
2623
0.050
Why?
Single-Blind Method
2
2015
313
0.050
Why?
Veins
2
1995
68
0.050
Why?
Specialty Boards
1
2024
42
0.050
Why?
Blood Pressure
2
2021
1765
0.050
Why?
Thromboplastin
1
2023
67
0.050
Why?
Physical Exertion
1
2004
204
0.050
Why?
Atherectomy
1
2023
37
0.050
Why?
Forecasting
2
2001
388
0.050
Why?
Clinical Trials as Topic
1
2008
1064
0.050
Why?
Survival Analysis
2
2004
1378
0.050
Why?
Diagnostic Techniques, Cardiovascular
1
2002
16
0.050
Why?
Sexism
1
2023
70
0.050
Why?
Preoperative Care
2
2002
396
0.040
Why?
Numbers Needed To Treat
1
2021
7
0.040
Why?
Morbidity
1
2023
319
0.040
Why?
Off-Label Use
1
2022
50
0.040
Why?
Mobility Limitation
1
2022
68
0.040
Why?
Psychomotor Performance
1
2004
329
0.040
Why?
Adrenal Cortex Hormones
1
2025
486
0.040
Why?
Societies, Medical
2
2009
907
0.040
Why?
Hemangioendothelioma, Epithelioid
1
2001
7
0.040
Why?
Vascular Neoplasms
1
2001
19
0.040
Why?
Cadaver
1
2022
304
0.040
Why?
Angioplasty
1
2001
49
0.040
Why?
Enzyme Inhibitors
1
2004
823
0.040
Why?
Oxygen Consumption
1
2004
721
0.040
Why?
Frailty
1
2024
208
0.040
Why?
Aneurysm, False
1
2001
46
0.040
Why?
Mass Screening
1
2009
1307
0.040
Why?
Equipment Failure
1
2001
112
0.040
Why?
Tetrazoles
1
2001
50
0.040
Why?
Habits
1
2020
47
0.040
Why?
Tissue Plasminogen Activator
1
2022
245
0.040
Why?
Heart Failure
1
2014
2329
0.040
Why?
Educational Measurement
1
2024
331
0.040
Why?
Joint Dislocations
1
2021
61
0.040
Why?
Physician's Role
1
2002
225
0.040
Why?
Arterial Pressure
1
2021
130
0.040
Why?
Empathy
1
2022
184
0.040
Why?
Stents
2
2022
554
0.040
Why?
Severity of Illness Index
2
2008
2921
0.040
Why?
Internationality
1
2020
156
0.040
Why?
Diagnostic Imaging
3
2007
340
0.040
Why?
Radiography, Interventional
1
2001
128
0.040
Why?
Toe Joint
1
1999
5
0.040
Why?
Prosthesis Design
1
2022
358
0.040
Why?
Pulse
1
1999
30
0.040
Why?
Knee Injuries
1
2021
121
0.040
Why?
Proprotein Convertase 9
1
2020
88
0.040
Why?
Artificial Limbs
1
2003
215
0.040
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2001
228
0.040
Why?
Pulsatile Flow
1
1999
62
0.040
Why?
Internal Medicine
1
2002
280
0.040
Why?
Pregnancy Complications, Infectious
1
2024
438
0.040
Why?
Metatarsal Bones
1
1999
22
0.040
Why?
Debridement
1
1999
86
0.040
Why?
Patient Education as Topic
1
2024
770
0.040
Why?
Myocardial Revascularization
1
2019
85
0.030
Why?
Anxiety
1
2026
1125
0.030
Why?
Arteriovenous Fistula
1
1998
36
0.030
Why?
Catheters, Indwelling
1
1998
94
0.030
Why?
Clinical Trials, Phase III as Topic
1
2018
116
0.030
Why?
Carotid Arteries
1
2019
206
0.030
Why?
Intraoperative Complications
1
1998
157
0.030
Why?
Purinergic P2Y Receptor Antagonists
1
2018
71
0.030
Why?
Postoperative Care
1
2019
301
0.030
Why?
Coronary Disease
1
2000
380
0.030
Why?
Antiviral Agents
1
2023
779
0.030
Why?
Combined Modality Therapy
1
2020
1271
0.030
Why?
Diagnosis, Differential
2
2014
1503
0.030
Why?
Knee Joint
1
2021
453
0.030
Why?
Neck
1
1997
107
0.030
Why?
Age Factors
1
2004
3347
0.030
Why?
Administration, Oral
1
2019
872
0.030
Why?
Risk
1
2019
920
0.030
Why?
Depression
1
2026
1575
0.030
Why?
Multicenter Studies as Topic
1
2018
417
0.030
Why?
Blood Loss, Surgical
1
2016
117
0.030
Why?
Health Promotion
1
2022
786
0.030
Why?
Postoperative Hemorrhage
1
2016
106
0.030
Why?
Cardiology
1
2019
363
0.030
Why?
Fractures, Bone
1
2021
436
0.030
Why?
Aortic Rupture
1
1995
28
0.030
Why?
Foot
1
1996
109
0.030
Why?
Aorta, Abdominal
1
1995
51
0.030
Why?
Pain Measurement
2
2009
573
0.030
Why?
Groin
1
1994
13
0.030
Why?
Vaccination
1
2023
1449
0.030
Why?
Carotid Artery, External
1
1993
3
0.030
Why?
Orthopedic Equipment
1
1993
5
0.030
Why?
Venous Insufficiency
1
1993
12
0.020
Why?
Prosthesis Failure
1
1994
126
0.020
Why?
Glasgow Coma Scale
1
2014
211
0.020
Why?
Cerebral Revascularization
1
1993
22
0.020
Why?
Carotid Artery, Common
1
1993
31
0.020
Why?
Operative Time
1
2014
195
0.020
Why?
Cerebral Angiography
1
1993
121
0.020
Why?
Ankle
1
1993
73
0.020
Why?
Arteritis
1
1993
23
0.020
Why?
Tomography, X-Ray Computed
2
2016
2786
0.020
Why?
Pressure
1
1993
221
0.020
Why?
Housing
1
1993
142
0.020
Why?
Surgical Wound Infection
1
2016
349
0.020
Why?
Exercise
1
2004
2213
0.020
Why?
Longitudinal Studies
2
1999
3017
0.020
Why?
Inflammation
1
2023
2919
0.020
Why?
Nursing Homes
1
1993
171
0.020
Why?
Practice Patterns, Physicians'
1
2020
1408
0.020
Why?
Cohort Studies
1
2022
6077
0.020
Why?
Pain
2
2009
790
0.020
Why?
Sickness Impact Profile
1
2011
67
0.020
Why?
Lung
1
2004
4122
0.020
Why?
Pneumonia
1
2016
635
0.020
Why?
Child
2
2020
22693
0.020
Why?
Equipment Safety
1
2009
38
0.020
Why?
Cross-Sectional Studies
1
2021
5899
0.020
Why?
Ligation
1
2008
88
0.020
Why?
Anti-Bacterial Agents
1
1999
1942
0.020
Why?
Illinois
1
2008
47
0.020
Why?
Tissue and Organ Harvesting
1
2008
69
0.020
Why?
Smoking
1
2015
1486
0.020
Why?
Equipment Design
1
2009
520
0.020
Why?
Length of Stay
1
2014
1358
0.020
Why?
Cardiovascular Agents
1
2009
165
0.020
Why?
Ulcer
1
2007
37
0.020
Why?
Constriction, Pathologic
1
2008
240
0.020
Why?
Magnetic Resonance Angiography
1
2009
249
0.020
Why?
Cerebral Arterial Diseases
1
2007
50
0.020
Why?
Evidence-Based Medicine
1
2009
731
0.010
Why?
Drug Carriers
1
2006
138
0.010
Why?
Infusions, Intravenous
1
2006
432
0.010
Why?
Sterol O-Acyltransferase
1
2004
6
0.010
Why?
Acetamides
1
2004
42
0.010
Why?
Reference Values
1
2006
796
0.010
Why?
Cost-Benefit Analysis
1
2007
640
0.010
Why?
Drug Administration Schedule
1
2006
790
0.010
Why?
Hemodynamics
1
2009
1114
0.010
Why?
Hyperemia
1
2004
49
0.010
Why?
Blood Flow Velocity
1
2004
419
0.010
Why?
Ultrasonography
1
2006
788
0.010
Why?
Treatment Refusal
1
2002
99
0.010
Why?
Lipids
1
2006
714
0.010
Why?
World Health Organization
1
2000
104
0.010
Why?
Sulfonamides
1
2004
594
0.010
Why?
Costs and Cost Analysis
1
2000
217
0.010
Why?
Heart Function Tests
1
2000
59
0.010
Why?
Algorithms
1
2007
1849
0.010
Why?
Epoprostenol
1
1999
132
0.010
Why?
Aneurysm, Ruptured
1
1998
38
0.010
Why?
Models, Theoretical
1
2000
561
0.010
Why?
Gangrene
1
1996
11
0.010
Why?
Patient Satisfaction
1
2000
706
0.010
Why?
Ultrasonography, Doppler, Color
1
1995
37
0.010
Why?
Embolization, Therapeutic
1
1998
246
0.010
Why?
Health Status
1
2000
827
0.010
Why?
Takayasu Arteritis
1
1993
16
0.010
Why?
Behcet Syndrome
1
1993
19
0.010
Why?
Infant, Newborn
1
1999
6460
0.000
Why?
Nehler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)